Lung Cancer

Tecemotide (INN; emepepimut-S (USAN); formerly known as BLP25 or EMD 531444) is a synthetic lipopeptide that is used as antigen in an investigational therapeutic cancer vaccine (formerly known as Stimuvax, L-BLP25, BLP25 liposomal vaccine, or BLP25 liposome vaccine).

Read more in the app

New strategy to boost the effect of immunotherapy in the most aggressive form of lung cancer - EurekAlert!

Non-smokers account for 20% of lung cancer diagnoses - EurekAlert!

Here’s how air pollution may trigger lung cancer

Air Pollution 'Strongly Associated' With DNA Mutations Tied to Lung Cancer

Scientists discover protein that helps lung cancer spread to the brain - EurekAlert!

Air pollution may contribute to development of lung cancer in never-smokers, new study finds - EurekAlert!

Effect of respiratory phase on three-dimensional quantitative parameters of pulmonary subsolid nodules in low-dose computed tomography screening for lung cancer - EurekAlert!

New Hope for Lung Cancer: Scientists Develop Targeted Genetic Treatment

Smart nanoparticles launch genetic attack on lung cancer and cystic fibrosis

New biomarker may guide best use of KRAS inhibitors in lung cancer - EurekAlert!

Identifying lung cancer in Emergency Department patients outside national lung cancer screening guidelines - EurekAlert!

NRG Oncology adds new committee leaders in lung cancer and imaging - EurekAlert!

Detecting lung cancer 4 months earlier at the GP using artificial intelligence - EurekAlert!

Unraveling the oncogenic potential of microRNAs in lung cancer - EurekAlert!

Scientists Discover Unexpected Link Between Diet And Lung Cancer Risk

Eat better, breathe easier? Research points to link between diet, lung cancer - EurekAlert

Eat better, breathe easier? Research points to link between diet, lung cancer

Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation - EurekAlert

Lung Cancer Is Rising in Non-Smokers, And This Could Be Why

Research pinpoints weakness in lung cancer's defenses